The promise and perils of biotech in personalized healthcare: Can new regulatory pathways protect the vulnerable? (2018)
Attributed to:
FUTURE TARGETED HEALTHCARE MANUFACTURING HUB
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Publication URI: http://www.lse.ac.uk/accounting/assets/CARR/documents/R-R/Winter-2018/Issue-36-riskregulation-06.pdf
Type: Journal Article/Review
Volume: 36
Parent Publication: Risk & regulation
ISSN: 14736012